Exercise can be beneficial for people with amyotrophic lateral sclerosis (ALS), helping to preserve muscle strength and mobility for as long as possible, and enhancing overall quality of life.

Many people have fasciculations, called muscle twitching, at some point. Often, it’s caused by drinking too much coffee, lack of sleep, or a trapped nerve. However, repeated episodes of fasciculations could be a sign of a neuromuscular disorder such as amyotrophic lateral sclerosis (ALS).

After a diagnosis of amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative, muscle-wasting condition that doesn’t have a cure, your focus should be on what you can do to help maintain your quality of life.

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that damages motor neurons, eventually leading to disability and an inability to perform everyday tasks, including difficulty with eating and drinking.

Masitinib, formerly known as AB1010, is an oral medication that's being developed as a potential add-on treatment for slowing disease progression in amyotrophic lateral sclerosis (ALS).

Qalsody (tofersen) is an injection therapy conditionally approved in the U.S. for the treatment of amyotrophic lateral sclerosis (ALS) associated with mutations in the SOD1 gene (SOD1-ALS).

Radicava (edaravone) is an approved infusion therapy used to slow functional decline in people with amyotrophic lateral sclerosis (ALS).

Exservan (riluzole oral film) is an approved oral treatment for amyotrophic lateral sclerosis (ALS). The medication can increase survival without the need for a tracheostomy — a tube inserted through the neck into the windpipe to help with breathing.

Tiglutik (riluzole oral suspension) is a liquid formulation of riluzole approved for treating amyotrophic lateral sclerosis (ALS). The medication can slow disease progression, extending survival time or the need for a tracheostomy, which is when a breathing tube is inserted through the neck into the trachea.

Rilutek (riluzole) is an oral treatment approved to slow the progression of amyotrophic lateral sclerosis (ALS). The therapy can extend survival and/or the time to a tracheostomy — a procedure wherein a tube is inserted through the neck into the windpipe to help with breathing.